Pharmaceutical innovation and generic challenge: recent trends and causal factors
暂无分享,去创建一个
Purpose – This paper aims to analyze the present trends in pharmaceutical innovation and the impact of generic competition.Design/methodology/approach – A secondary research was conducted to collect data related to new drug approvals of various classes over previous years; trends of investment in research and development; and the pipeline of new drug products of pharmaceutical companies.Findings – While the new molecular entity (NME) approval rate has not improved over previous years, innovators have been aggressively pursuing the radical innovation process. Further, there has been a significant increase in incremental innovation. Pharmaceutical companies' investment in research has gone up resulting in higher number of application for new drug approvals. In India, pharmaceutical companies have significantly increased their research investment. However, the NME pipeline is still slim though there has been a significant surge in generic filings.Originality/value – It provides a concise understanding of tre...
[1] H. Grabowski,et al. Are the economics of pharmaceutical research and development changing? , 2012, PharmacoEconomics.
[2] E. Berndt,et al. Prescription drug spending trends in the United States: looking beyond the turning point. , 2008, Health affairs.
[3] Dennis Z. Kvesic,et al. Product Lifecycle Management: Marketing Strategies for the Pharmaceutical Industry , 2008 .